Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Product › Details

tafasitamab (MOR208 / XmAb5574)

Products Next higher product group antibody cancer drug
Period Status 2020-08-01 registration start
Organisations Organisation MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR)
  Group MorphoSys (Group)
  Organisation 2 Xencor Inc. (Nasdaq: XNCR)
     

   
Record changed: 2020-11-11

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for tafasitamab (MOR208 / XmAb5574)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top